#These authors contributed equally to this work. References 1 Reiss K, Ludwig A, Saftig P. Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 2006; 111:985-1006. 2 Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006; 54:S67-80. 3 Kawaguchi M, Mitsuhashi Y, Kondo S. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis. Br J Dermatol 2005; 152:915-19. 4 Piepkorn M, Pittelkow MR, Cook PW. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 1998; 111:715-21. 5 Higashiyama S, Nanba D. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. Biochim Biophys Acta 2005; 1751:110-17. 6 Loechel F, Fox JW, Murphy G et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000; 278:511-15. 7 Edmondson SR, Thumiger SP, Kaur P et al. Insulin-like growth factor binding protein-3 (IGFBP-3) localizes to and modulates proliferative epidermal keratinocytes in vivo. Br J Dermatol 2005; 152:225-30. 8 Rychly J, Nebe B. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction. Curr Pharm Des 2006; 12:3799-806. 9 Hundhausen C, Schulte A, Schulz B et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol 2007; 178:8064-72. 10 Thabet MM, Huizinga TW. Drug evaluation: apratastat, a novel TACE ⁄ MMP inhibitor for rheumatoid arthritis. Curr Opin Investig Drugs 2006; 7:1014-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.